"Soft tissue sarcoma" trang 1 - tải miễn phí từ tailieuXANH
Combination therapy with Olaratumab/ doxorubicin in advanced or metastatic soft tissue sarcoma - a single-Centre experience

Combination therapy with Olaratumab/ doxorubicin in advanced or metastatic soft tissue sarcoma - a single-Centre experience
8    56    0
Diagnostic value of MRI for detecting recurrent soft-tissue sarcoma in a long-term analysis at a multidisciplinary sarcoma center

Diagnostic value of MRI for detecting recurrent soft-tissue sarcoma in a long-term analysis at a multidisciplinary sarcoma center
8    48    1
Albumin-bound paclitaxel and gemcitabine combination therapy in soft tissue sarcoma

Albumin-bound paclitaxel and gemcitabine combination therapy in soft tissue sarcoma
6    93    0
Treatment patterns and survival in an exhaustive French cohort of pazopanibeligible patients with metastatic soft tissue sarcoma (STS)

Treatment patterns and survival in an exhaustive French cohort of pazopanibeligible patients with metastatic soft tissue sarcoma (STS)
9    52    0
Efficacy of pazopanib monotherapy in patients who had been heavily pretreated for metastatic soft tissue sarcoma: A retrospective case series

Efficacy of pazopanib monotherapy in patients who had been heavily pretreated for metastatic soft tissue sarcoma: A retrospective case series
7    58    0
Development of nomograms for prognostication of patients with primary soft tissue sarcomas of the trunk and extremity: Report from the Bone and Soft Tissue Tumor Registry in Japan

Development of nomograms for prognostication of patients with primary soft tissue sarcomas of the trunk and extremity: Report from the Bone and Soft Tissue Tumor Registry in Japan
12    63    0
Safety and efficacy of Pazopanib in advanced soft tissue sarcoma: PALETTE (EORTC 62072) subgroup analyses

Safety and efficacy of Pazopanib in advanced soft tissue sarcoma: PALETTE (EORTC 62072) subgroup analyses
7    58    0
AZGP1 inhibits soft tissue sarcoma cells invasion and migration

AZGP1 inhibits soft tissue sarcoma cells invasion and migration
8    63    0
Levels of activated platelet-derived microvesicles in patients with soft tissue sarcoma correlate with an increased risk of venous thromboembolism

Levels of activated platelet-derived microvesicles in patients with soft tissue sarcoma correlate with an increased risk of venous thromboembolism
11    91    0
Race is an independent predictor of survival in patients with soft tissue sarcoma of the extremities

Race is an independent predictor of survival in patients with soft tissue sarcoma of the extremities
6    61    0
Harnessing soft tissue sarcoma with lowdose pazopanib – a matter of blood levels

Harnessing soft tissue sarcoma with lowdose pazopanib – a matter of blood levels
3    55    0
Surrogacy of intermediate endpoints for overall survival in randomized controlled trials of first-line treatment for advanced soft tissue sarcoma in the pre- and postpazopanib era: A meta-analytic evaluation

Surrogacy of intermediate endpoints for overall survival in randomized controlled trials of first-line treatment for advanced soft tissue sarcoma in the pre- and postpazopanib era: A meta-analytic evaluation
9    60    0
Prognostic value of the fibrinogen/albumin ratio (FAR) in patients with operable soft tissue sarcoma

Prognostic value of the fibrinogen/albumin ratio (FAR) in patients with operable soft tissue sarcoma
10    52    0
Value of peri-operative chemotherapy in patients with CINSARC high-risk localized grade 1 or 2 soft tissue sarcoma: Study protocol of the target selection phase III CHIC-STS trial

Value of peri-operative chemotherapy in patients with CINSARC high-risk localized grade 1 or 2 soft tissue sarcoma: Study protocol of the target selection phase III CHIC-STS trial
8    46    0
SPARC expression in patients with high-risk localized soft tissue sarcoma treated on a randomized phase II trial of neo/adjuvant chemotherapy

SPARC expression in patients with high-risk localized soft tissue sarcoma treated on a randomized phase II trial of neo/adjuvant chemotherapy
8    50    0
Risk factors for pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment: A single-institute analysis

Risk factors for pneumothorax in advanced and/or metastatic soft tissue sarcoma patients during pazopanib treatment: A single-institute analysis
7    48    0
Prognostic implications of PD-L1 expression in patients with soft tissue sarcoma

Prognostic implications of PD-L1 expression in patients with soft tissue sarcoma
7    46    0
Preoperative platelet-lymphocyte ratio is superior to neutrophil-lymphocyte ratio as a prognostic factor for soft-tissue sarcoma

Preoperative platelet-lymphocyte ratio is superior to neutrophil-lymphocyte ratio as a prognostic factor for soft-tissue sarcoma
11    63    0
Efficacy of combination-chemotherapy with pirarubicin, ifosfamide, and etoposide for soft tissue sarcoma: A single-institution retrospective analysis

Efficacy of combination-chemotherapy with pirarubicin, ifosfamide, and etoposide for soft tissue sarcoma: A single-institution retrospective analysis
6    72    0
A retrospective chart review of drug treatment patterns and clinical outcomes among patients with metastatic or recurrent soft tissue sarcoma refractory to one or more prior chemotherapy treatments

A retrospective chart review of drug treatment patterns and clinical outcomes among patients with metastatic or recurrent soft tissue sarcoma refractory to one or more prior chemotherapy treatments
7    61    0
Đã phát hiện trình chặn quảng cáo AdBlock
Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.